Skip to main content
Equibles

PMDI · Psychemedics Corp · Metrics

Track PMDI — free

Use PMDI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research PMDI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.49 At close · Sep 23
Rebalance outlook locked
Market Cap
$15.21M
Shares
6.11M
Volume · Sep 23 99 Avg daily vol (3 sessions) 6699

PMDI metrics

61 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$2.49
Market cap
$15.21M

Price action

20 metrics
Price change (1W)
—
Price change (30D)
+0.0%
Price change (3M)
+13.2%
Price change (6M)
+68.2%
Price change (YTD)
+55.6%
Price change (1Y)
+18.0%
Trailing year
Price change (5Y)
—
52-week high
$2.50
52-week low
$1.38
Change from 52-week high
-0.4%
Change from 52-week low
+80.4%
Annualized volatility
88.8%
Annualized volatility (3M)
—
Beta
—
RSI (14D)
63.9
Price vs SMA 50
+33.6%
Price vs SMA 200
+20.3%
Avg volume (3M)
—
Relative volume
—
Average dollar volume
—

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
6.11M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.8×
reciprocal yield 129.4%
P / book
3.0
reciprocal yield 33.7%
FCF yield
5.8%
TTM · current market cap
Buyback yield
—
P / FCF
17.3
reciprocal yield 5.8%
P / operating cash flow
16.4
reciprocal yield 6.1%
Earnings yield
-12.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
1.3×
reciprocal yield 77.4%
EV / revenue historical average (5Y)
1.2×
reciprocal yield 82.0%
EV / EBIT historical average (3Y)
335.4×
reciprocal yield 0.3%
EV / EBIT historical average (5Y)
335.4×
reciprocal yield 0.3%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
36.1%
Operating margin
-9.6%
Trailing 12 months
Net margin
-9.5%
Gross profit (TTM)
$7.10M
Operating profit (TTM)
−$1.89M
Net income (TTM)
−$1.86M
Trailing 12 months
Diluted EPS (TTM)
$-0.68
FCF margin
4.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.84

Growth

11 metrics
Revenue growth YoY
-11.5%
Year over year
Net income growth YoY
—
Revenue (TTM)
$19.68M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2.1%
Year over year · more shares
Revenue CAGR (3Y)
-7.5%
Revenue CAGR (5Y)
-12.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+55.8%
FCF CAGR (5Y)
-19.7%

Quality

14 metrics
Return on equity
-36.3%
Return on assets
-22.4%
Debt / equity
—
Current ratio
1.8
EBITDA (TTM)
−$3.37M
Free cash flow (TTM)
$878,000
Quick ratio
1.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.42M
Total assets
$8.32M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$929,000
Capital expenditures (TTM)
$51,000
R&D (TTM)
$749,000
SG&A (TTM)
—
Stock compensation (TTM)
$917,000
R&D / revenue
3.8%
Stock compensation / revenue
4.7%

Ownership (13F)

3 metrics
13F filers
—
13F filer change QoQ
—
Institutional ownership
—

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 567.7 days to cover
Days to cover
567.7d
Short-squeeze score
43 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 806517 CUSIP 744375304 Visit website Investor relations